(Reuters) - The National Institute for Health and Clinical Excellence
said on Wednesday it believed the drug, also known as
varenicline, was a good way to help people who wanted to quit
smoking.
Champix, which is sold as Chantix in the United States,
targets the specific receptor to which nicotine binds, thereby
reducing the severity of the smoker's urge to smoke. It was
approved as safe and effective by European and U.S. regulators
last year.
Read more at Reuters.com Government Filings News
said on Wednesday it believed the drug, also known as
varenicline, was a good way to help people who wanted to quit
smoking.
Champix, which is sold as Chantix in the United States,
targets the specific receptor to which nicotine binds, thereby
reducing the severity of the smoker's urge to smoke. It was
approved as safe and effective by European and U.S. regulators
last year.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment